Anti-Epileptic Drugs Flashcards
0
Q
Describe the MoA of sodium channel blockers
A
- Binds to internal face of sodium channels in its inactivated state
- Prevents depolarisation of neurone, preventing action potential generation.
1
Q
What are the four classes of AEDs?
A
- Enhancement of GABA mediated inhibition
- Voltage-gated sodium channel blockers
- Calcium channel blockers
- Inhibition of glutamate release
2
Q
Name three types of VGSC blockers
A
- Carbamazepine
- Phenytoin
- Lamotrigene
3
Q
Describe the properties of carbamazepine.
A
- Linear PK
- CYP450 inducer
- Half-life decreases from 30 to 15hrs with repeated use
- Used to treat generalised tonic-clinic seizures and partial seizures
4
Q
List some ADRs of carbamazepine
A
- Drowsiness, dizziness, ataxia, motor disturbances, paresthesia, anaesthesia
- Nausea and vomitting
- Variations in BP
- Rashes, bone marrow suppression
5
Q
List some DDIs of carbamazepine
A
- Reduces levels of warfarin, phenytoin, corticosteroids, OCP
6
Q
Describe the properties of phenytoin
A
- Well absorbed, 90% bound to plasma proteins
- Linear PK at sub-therapeutic levels, non-linear PK at therapeutic levels
- Variable half life (6-24hr) must be monitored
- CYP450 inducer
- Used to treat generalised tonic-clonic and partial seizures
7
Q
List some ADRs of phenytoin
A
- Dizziness, ataxia, headaches, nystagmus
- Gingival hyperplasia
- Hypersensitivity reactions (Stevens Johnson syndrome)
8
Q
List some DDIs of phenytoin
A
- Plasma levels are increased if taken alongside valproate due to competitive binding
- Reduces level of OCP
- Increases level of cimetidine
9
Q
Describe the properties of Lamotrigine
A
- Well absorbed
- Linear PK
- Half life 24 hrs
- Fewer DDIs and ADL
- Used to treat generalised tonic-clonic, partial, and absent seizures
- Unable to cross the placental barrier
10
Q
List some ADRs of Lamotrigine
A
- Dizziness, ataxia, and somnolence
- Nausea
- Skin rashes
11
Q
List some DDIs of Lamotrigine
A
- Adjunct therapy with other AEDs
- Plasma levels are reduced by OCP
- Plasma levels are increased by valproate due to competitive binding